IFLR1000

Tellacq SKr105 million acquisition of 75% stake in Nordic Biosite

15/5/2018
Private acquisition
Select tab

SKr 105 million

$ 10.933 million

Announced

15/5/2018

Overview:

  • Healthcare investment group Tellacq has agreed to acquire a 75% stake in Nordic Biosite for SKr105 million.

Prin Shasiharan - Researcher

Jurisdiction:

Sweden

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
Cederquist

Party: Tellacq (Acquirer)

Setterwalls

Party: Nordic Biosite (Seller)

Related deals